Robin Shaw

1.5k total citations · 1 hit paper
25 papers, 852 citations indexed

About

Robin Shaw is a scholar working on Molecular Biology, Oncology and Economics and Econometrics. According to data from OpenAlex, Robin Shaw has authored 25 papers receiving a total of 852 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Economics and Econometrics. Recurrent topics in Robin Shaw's work include Merger and Competition Analysis (2 papers), Angiogenesis and VEGF in Cancer (2 papers) and Bioactive Compounds and Antitumor Agents (1 paper). Robin Shaw is often cited by papers focused on Merger and Competition Analysis (2 papers), Angiogenesis and VEGF in Cancer (2 papers) and Bioactive Compounds and Antitumor Agents (1 paper). Robin Shaw collaborates with scholars based in United Kingdom, United States and Italy. Robin Shaw's co-authors include Matthew L. Springer, William Blanco-Bose, Philip C. Ursell, Randall J. Lee, Helen M. Blau, Paul Simpson, Karen Blyth, Pauline Hagel, James K. Kindahl and William Clark and has published in prestigious journals such as Circulation, The Journal of Experimental Medicine and The EMBO Journal.

In The Last Decade

Robin Shaw

21 papers receiving 815 citations

Hit Papers

VEGF Gene Delivery to Myocardium 2000 2026 2008 2017 2000 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robin Shaw United Kingdom 12 469 260 155 105 93 25 852
Seung Hyun Hong South Korea 12 450 1.0× 414 1.6× 81 0.5× 549 5.2× 98 1.1× 29 1.1k
Chen Xia China 15 540 1.2× 340 1.3× 236 1.5× 215 2.0× 206 2.2× 22 1.5k
Arne Bartol Germany 7 380 0.8× 115 0.4× 67 0.4× 79 0.8× 103 1.1× 10 771
Haiying Pan United States 14 268 0.6× 196 0.8× 71 0.5× 74 0.7× 50 0.5× 26 526
Youngkyun Kim South Korea 19 535 1.1× 132 0.5× 35 0.2× 86 0.8× 67 0.7× 38 1.0k
Brock Reeve United States 10 307 0.7× 194 0.7× 60 0.4× 302 2.9× 74 0.8× 13 661
Timo Schinköthe Germany 17 287 0.6× 190 0.7× 90 0.6× 592 5.6× 82 0.9× 47 1.2k
Guoyan Wang China 12 439 0.9× 150 0.6× 91 0.6× 131 1.2× 112 1.2× 39 1.0k
Scott M. Weissman United States 13 275 0.6× 226 0.9× 56 0.4× 288 2.7× 219 2.4× 24 1.1k
Roberto Baelo Álvarez Spain 17 520 1.1× 366 1.4× 129 0.8× 178 1.7× 43 0.5× 52 1.1k

Countries citing papers authored by Robin Shaw

Since Specialization
Citations

This map shows the geographic impact of Robin Shaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Shaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Shaw more than expected).

Fields of papers citing papers by Robin Shaw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin Shaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Shaw. The network helps show where Robin Shaw may publish in the future.

Co-authorship network of co-authors of Robin Shaw

This figure shows the co-authorship network connecting the top 25 collaborators of Robin Shaw. A scholar is included among the top collaborators of Robin Shaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin Shaw. Robin Shaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Galbraith, Laura C.A., Robin Shaw, Rajan Veeratterapillay, et al.. (2025). Loss of ARID1A accelerates prostate tumourigenesis with a proliferative collagen-poor phenotype through co-operation with AP1 subunit cFos. British Journal of Cancer. 132(6). 502–512.
2.
Shaw, Robin, et al.. (2023). MBTPS2 acts as a regulator of lipogenesis and cholesterol synthesis through SREBP signalling in prostate cancer. British Journal of Cancer. 128(11). 1991–1999. 8 indexed citations
3.
Sandilands, Emma, Álvaro Román‐Fernández, Sérgio Lilla, et al.. (2023). PTEN deficiency exposes a requirement for an ARF GTPase module for integrin‐dependent invasion in ovarian cancer. The EMBO Journal. 42(18). e113987–e113987. 4 indexed citations
4.
Edwards, Sarah C., Ann Hedley, Anna Kilbey, et al.. (2022). PD-1 and TIM-3 differentially regulate subsets of mouse IL-17A–producing γδ T cells. The Journal of Experimental Medicine. 220(2). 35 indexed citations
5.
Taurino, Giuseppe, Víctor H. Villar, Martina Chiu, et al.. (2022). Mesenchymal stromal cells cultured in physiological conditions sustain citrate secretion with glutamate anaplerosis. Molecular Metabolism. 63. 101532–101532. 6 indexed citations
6.
McGuinness, David, et al.. (2021). Searchlight: automated bulk RNA-seq exploration and visualisation using dynamically generated R scripts. BMC Bioinformatics. 22(1). 411–411. 16 indexed citations
7.
Castino, Giovanni Francesco, Susan Mason, William Clark, et al.. (2021). MICAL1 regulates actin cytoskeleton organization, directional cell migration and the growth of human breast cancer cells as orthotopic xenograft tumours. Cancer Letters. 519. 226–236. 14 indexed citations
8.
Humpton, Timothy J., H. G. HALL, Christos Kiourtis, et al.. (2021). p53-mediated redox control promotes liver regeneration and maintains liver function in response to CCl4. Cell Death and Differentiation. 29(3). 514–526. 23 indexed citations
9.
McColl, Alison, Robin Shaw, Philip J. Cowen, et al.. (2021). No evidence for differential gene expression in major depressive disorder PBMCs, but robust evidence of elevated biological ageing. Translational Psychiatry. 11(1). 404–404. 20 indexed citations
10.
Rushworth, Linda, Victoria Harle, Peter Repiščák, et al.. (2020). In vivo CRISPR/Cas9 knockout screen: TCEAL1 silencing enhances docetaxel efficacy in prostate cancer. Life Science Alliance. 3(12). e202000770–e202000770. 14 indexed citations
11.
Hall, John W., et al.. (2008). Battlefield tourism in Turkey : an empirical analysis of British ex-colonial event attendance. Griffith Research Online (Griffith University, Queensland, Australia). 1–8. 1 indexed citations
12.
Hagel, Pauline & Robin Shaw. (2007). The influence of delivery mode on consumer choice of university. Deakin Research Online (Deakin University). 531–536. 12 indexed citations
13.
Shaw, Robin & Paul Simpson. (1985). The Monopolies Commission and the Process of Competition. Fiscal Studies. 6(1). 82–96. 1 indexed citations
14.
Shaw, Robin & Patricia Simpson. (1984). The Monopolies Commission and the persistence of monopoly. OpenGrey (Institut de l'Information Scientifique et Technique). 3 indexed citations
15.
Shaw, Robin, et al.. (1980). The social and economic implications of trypanosomiasis control. A study of its impact on livestock production and rural development in Northern Nigeria.. 22 indexed citations
16.
Shaw, Robin. (1980). NEW ENTRY AND THE COMPETITIVE PROCESS IN THE U. K. FERTILISER INDUSTRY1. Scottish Journal of Political Economy. 27(1). 1–16. 2 indexed citations
17.
Shaw, Robin & Susan A. Shaw. (1977). PATENT EXPIRY AND COMPETITION IN POLYESTER FIBRES. Scottish Journal of Political Economy. 24(2). 117–132. 7 indexed citations
18.
Shaw, Robin, et al.. (1976). Industry and competition: Industrial case studies. Medical Entomology and Zoology. 4 indexed citations
19.
Shaw, Robin, et al.. (1973). The Principles of Modern Management.. Journal of the Royal Statistical Society Series A (General). 136(2). 274–274. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026